2020
DOI: 10.1136/esmoopen-2020-001090
|View full text |Cite
|
Sign up to set email alerts
|

Impact of COVID-19 on cancer service delivery: results from an international survey of oncology clinicians

Abstract: ObjectivesTo report clinician-perceived changes to cancer service delivery in response to COVID-19.DesignMultidisciplinary Australasian cancer clinician survey in collaboration with the European Society of Medical Oncology.SettingBetween May and June 2020 clinicians from 70 countries were surveyed; majority from Europe (n=196; 39%) with 1846 COVID-19 cases per million people, Australia (AUS)/New Zealand (NZ) (n=188; 38%) with 267/236 per million and Asia (n=75; 15%) with 121 per million at time of survey distr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
32
0
2

Year Published

2021
2021
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 20 publications
(38 citation statements)
references
References 13 publications
4
32
0
2
Order By: Relevance
“…In November of 2020, we published results from an international survey of oncology clinicians (conducted May-June 2020), with pertinent findings including 89% of oncology clinicians reporting altering cancer management, significantly fewer patient consultations per week and an almost 8-fold increase in use of telehealth for patient consultations, with many clinicians expressing concerns that increased telehealth use may negatively impact patient outcomes. 1 Here, we describe findings from a follow-up survey, conducted from 27 th September to 7 th J o u r n a l P r e -p r o o f November, intended to explore how attitudes and practices evolved over the pandemic period in 2020.…”
Section: Highlightsmentioning
confidence: 99%
“…In November of 2020, we published results from an international survey of oncology clinicians (conducted May-June 2020), with pertinent findings including 89% of oncology clinicians reporting altering cancer management, significantly fewer patient consultations per week and an almost 8-fold increase in use of telehealth for patient consultations, with many clinicians expressing concerns that increased telehealth use may negatively impact patient outcomes. 1 Here, we describe findings from a follow-up survey, conducted from 27 th September to 7 th J o u r n a l P r e -p r o o f November, intended to explore how attitudes and practices evolved over the pandemic period in 2020.…”
Section: Highlightsmentioning
confidence: 99%
“…This survey reported a 7.7-fold increase in the proportion of consultations using telehealth, however 25% of clinicians reported concerns that increased telehealth could lead to a worsened patient survival because of less frequent physical assessments. 13 Concerns about the psychological impact of new models of care should also be taken into consideration.…”
Section: Discussionmentioning
confidence: 99%
“…Our survey does not put the responses into the context of case numbers at the time of the survey, however the survey by Chazan et al reports that 88.8% of respondents altered cancer management or the delivery of cancer services, with similar rates across Europa, Asia and Australia/ New Zealand, despite disparities in COVID-19 case numbers. 13 The survey was open for a short duration, only capturing a snapshot of experiences and strategies implemented during the pandemic. It is possible that there is respondent bias in the sense that respondents working in hospitals implementing strategies aimed at patient prioritisation were more willing to take part in the survey.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Expert panels have proposed strategies to balance cancerrelated risks and benefits with the increased risk of COVID-19 [11,12], leading some institutions to delay treatments and nonurgent interventions in order to encourage social distancing [13,14]. Delays in cancer treatment may increase 5-year cancer-related mortality by 4.8%-16.6% (depending on cancer type) [15]; delaying cancer care has been found to be associated with increased cancer-specific mortality, which exceeds COVID-19 mortality [16].…”
Section: Introductionmentioning
confidence: 99%